Pretargeted radioimmunotherapy for hematologic and other malignancies - Wikidata - awgldk - TriplyDB

Pretargeted radioimmunotherapy for hematologic and other malignancies

Pretargeted radioimmunotherapy for hematologic and other malignancies

http://www.wikidata.org/entity/Q34113941

about

Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models Radioimmunotherapy of human tumours Radiation-induced tumor neoantigens: imaging and therapeutic implications.Chemically modified antibodies as diagnostic imaging agents Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Two-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles.Advances in hematopoietic stem cell transplantation in childhood and adolescent lymphomas.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter Mixture of PLA-PEG and biotinylated albumin enables immobilization of avidins on electrospun fibers.

P2860

Q27311386-20A0880B-65E0-4F66-B6BE-33C7758AA48A Q28088825-0420466F-9C9F-40B3-A9A8-E24C79624C67 Q30473856-E03C915F-3395-47F2-A30A-C1FE501031EB Q34441433-C0913C48-E608-440C-9E66-A1FDDFB5D155 Q35670632-63661DF7-4140-4A38-8A60-E7BD9C5AE933 Q36395999-4C3C2474-63C5-4C6A-92D2-1DB08037B17C Q36438435-6ACBF39B-9F2B-47E0-B168-40AD7326E4A7 Q36979074-49BF4AAE-ABFC-4C2A-A89F-5E03C1E86005 Q38700209-F61BA605-CC52-4152-BD66-E60A4B5C8A7F Q38834565-3FAE178A-A48F-4E8F-844A-9E4514392997 Q51131133-B94C103C-E738-4226-B41A-087FD99A0FFF

P2860

Pretargeted radioimmunotherapy for hematologic and other malignancies

http://www.wikidata.org/entity/Q34113941

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pretargeted radioimmunotherapy for hematologic and other malignancies

@ast

Pretargeted radioimmunotherapy for hematologic and other malignancies

@en

Pretargeted radioimmunotherapy for hematologic and other malignancies

@nl

type

label

Pretargeted radioimmunotherapy for hematologic and other malignancies

@ast

Pretargeted radioimmunotherapy for hematologic and other malignancies

@en

Pretargeted radioimmunotherapy for hematologic and other malignancies

@nl

prefLabel

Pretargeted radioimmunotherapy for hematologic and other malignancies

@ast

Pretargeted radioimmunotherapy for hematologic and other malignancies

@en

Pretargeted radioimmunotherapy for hematologic and other malignancies

@nl

P1433

Q34113941-14122387-DD76-4B64-AA0B-23049982DF50

P1476

Q34113941-02CD1E07-84B0-4E57-A82E-C86B8828F69C

P2093

Q34113941-6FFF8906-4E19-4220-B498-1C7C5E660F83

P2860

Q34113941-00AF9A5D-F346-49A0-B4C0-4A45E10F7AC7

Q34113941-03730E8B-1582-4A58-9842-3666B47C648A

Q34113941-05BB4129-4B7C-44CE-9FE0-E97B6DC2C1EB

Q34113941-06263939-F718-4D8F-A3F7-48B20FB92399

Q34113941-0697AAED-4A4B-4EE6-87A3-D3EFB252FB42

Q34113941-093C073A-1C10-4D99-B843-87F4785111AB

Q34113941-0975C0A5-AB78-438F-B357-4A671FDD5B5C

Q34113941-0B48CD38-B15F-4416-8AA6-C6CAC8B70590

Q34113941-0EB9A2CA-E1CC-41A8-8AE9-67D7303CC9B3

Q34113941-118BA260-37BF-4011-904F-F2C5EE0C76AE

P304

Q34113941-603AF074-FBC2-4B58-A527-7B87648CC00E

P31

Q34113941-1B6F55AA-642D-4393-80DC-4C1BA3BD98FC

P356

Q34113941-8D57A9C9-0FF0-4D0C-A832-BD8427F3AEFA

P433

Q34113941-540AD50A-913B-44FF-8827-463561246EB9

P478

Q34113941-4C52FFF9-AB6B-438F-9B11-4C6A80694E30

P50

Q34113941-75905CEA-B478-4B33-B136-EE4192FF794E

Q34113941-93CF3E36-4D99-42FD-9067-FA2AA85A04FC

P577

Q34113941-08D69F3D-E87C-41F9-9F6E-B5847A592214

P5875

Q34113941-90C4BFD7-41D2-4AF4-8603-4B05E0719D3E

P698

Q34113941-805C293D-DBFB-4914-BC12-F2F99C05BD8C

P932

Q34113941-E18E8EDE-2722-452F-9003-D43A32D3863A

P356

P1433

Cancer Biotherapy and Radiopharmaceuticals

P1476

Pretargeted radioimmunotherapy for hematologic and other malignancies

@en

P2093

John M Pagel

http://www.w3.org/2001/XMLSchema#string

P2860

AVIDIN. 1. THE USE OF (14-C)BIOTIN FOR KINETIC STUDIES AND FOR ASSAY

Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers.

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2.

Pretargeting with the affinity enhancement system for radioimmunotherapy.

The avidin-biotin complex in bioanalytical applications.

Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

P304

125-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CBR.2010.0759

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Roland B Walter

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43347407

http://www.w3.org/2001/XMLSchema#string

P698

20423225

http://www.w3.org/2001/XMLSchema#string

P932

2936263

http://www.w3.org/2001/XMLSchema#string